Clinical Trial Update: Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

View source ↗

Summary

A study investigated whether the formation of antibodies could predict clinical response in rheumatoid arthritis patients treated with four TNF-blocking agents.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TNF inhibitors (four agents)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis (RA) | Status: TERMINATED | Results posted: 2016-12-29